Effects of azeliragon on ADAS‐cog and CDR domains and individual items in patients with mild Alzheimer's disease and type 2 diabetes (T2D)
Year: 2020
Type: article
Source: Alzheimer s & Dementia
DOI: 10.1002/alz.041198
Authors: Aaron H. Burstein, Imogene Dunn, Ann M. Gooch, Carmen Valcarce
Institution: vTv Therapeutics (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3112374784
